Table 3.
Sporadic | MEN-1 | Metastatic | Total (%) | |
---|---|---|---|---|
CaStim | ||||
Correct localization | 33/39 (84) | 2/3 (67) | 3/3 (100) | 84 |
False-negative localization | 4/39 (11) | 1/3 (33) | 0/3 | 11 |
False-positive localization | 2/39 (5) | 0/3 | 0/3 | 4 |
US | ||||
Correct localization | 6/38 (16) | 0/3 (0) | 0/2 (0) | 14 |
False-negative localization | 27/38 (71) | 2/3 (67) | 2/2 (100) | 72 |
False-positive localization | 5/38 (13) | 1/3 (33) | 0/2 (0) | 14 |
CT | ||||
Correct localization | 13/38 (35) | 0/3 (0) | 1/3 (33) | 32 |
False-negative localization | 19/38 (49) | 1/3 (33) | 2/3 (67) | 50 |
False-positive localization | 6/38 (16) | 2/3 (67) | 0/3 (0) | 18 |
MRI | ||||
Correct localization | 11/38 (30) | 0/3 (0) | 0/3 (0) | 25 |
False-negative localization | 22/38 (57) | 2/3 (67) | 3/3 (100) | 61 |
False-positive localization | 5/38 (13) | 1/3 (33) | 0/3 (0) | 14 |
Data are expressed as number of patients/total patients (percentage), unless indicated differently.